<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04175756</url>
  </required_header>
  <id_info>
    <org_study_id>AAG-O-H-1627</org_study_id>
    <nct_id>NCT04175756</nct_id>
  </id_info>
  <brief_title>CAIman 5 Articulating Maryland in coloRECTAL Cancer Surgery</brief_title>
  <acronym>CAIRECTAL</acronym>
  <official_title>CAIman 5 Articulating Maryland in coloRECTAL Cancer Surgery. An Observational, Prospective, Post-marketing Clinical Follow-up Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aesculap AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aesculap AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This voluntary study is part of a Post-Market-Surveillance plan to proactively collect
      clinical data for the use of Caiman 5 articulating Maryland in colorectal surgery under daily
      clinical routine.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2, 2020</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Total operative time</measure>
    <time_frame>intraoperatively</time_frame>
    <description>Time between first incision and closure of the surgical incision</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>up to 4 months postoperative</time_frame>
    <description>Number of Complications: Wound infections, Urinary tract infections, Pulmonary infections, Other infections, Wound dehiscence, Anastomotic leak, Anastomotic bleeding, Other bleeding / hemorrhage, Intraabdominal abscess, Fistula, Peritonitis, Sepsis, Hernia, Stenosis Ileus, Ureter injury, Nerve injury, Cardiac complications, Other</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Handling characteristics</measure>
    <time_frame>intraoperative</time_frame>
    <description>Evaluation of performance and handling characteristics using a questionnaire containing 5-level Likert scales (excellent, very good, good, fair, poor)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated intraoperative blood loss</measure>
    <time_frame>intraoperative</time_frame>
    <description>intraoperative blood loss in ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time needed for TME</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Time between end of left flexure mobilization and stapling</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time needed for PME</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Time [in minutes] between end of left flexure mobilization and stapling</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time needed for CME</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Time [in minutes] between end of ileocolic vessels clipping and start of right flexure mobilization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time needed for right / hepatic colic flexure mobilization</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Time [in minutes] between end CME and start of resection of the mesentery of the small intestine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time needed for left / splenic colic flexure mobilization</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Time [in minutes] between clipping of inferior mesenteric vessels and start of TME, PME or corresponding)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stay in intensive care unit postop</measure>
    <time_frame>up to discharge (approximately 10 days postoperative)</time_frame>
    <description>Number of days postoperative until discharge from intensive care unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stay in intermediate care unit stay postop</measure>
    <time_frame>up to discharge (approximately 10 days postoperative)</time_frame>
    <description>Number of days postoperative until discharge from intermediate care unit stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First postoperative oral intake</measure>
    <time_frame>up to discharge (approximately 10 days postoperative)</time_frame>
    <description>Number of days until patient's first postoperative oral intake</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First postoperative stool</measure>
    <time_frame>up to discharge (approximately 10 days postoperative)</time_frame>
    <description>Number of days until patient's first postoperative stool after oral intake</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of excision: M.E.R.C.U.R.Y. criteria</measure>
    <time_frame>up to discharge (approximately 10 days postoperative)</time_frame>
    <description>quality of mesorectal excision according to criteria established in the &quot;Magnetic Resonance Imaging and Rectal Cancer European Equivalence Study&quot; (M.E.R.C.U.R.Y.)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Colorectal Cancer</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Caiman 5 articulating Maryland</intervention_name>
    <description>Laparoscopic colorectal surgery</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        adult patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient´s written informed consent

          -  Planned laparoscopic colorectal cancer surgery using Caiman 5 articulating Maryland
             (according to the IfU)

          -  Age ≥18 years

        Exclusion Criteria:

          -  Emergency surgery

          -  Pregnancy

          -  Participation in another surgical study, which might influence the intraoperative
             process

          -  Conversion to open surgery

          -  Conversion to another sealing / cutting instrument (instead of Caiman 5 articulating
             Maryland)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Niedergethmann, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alfried Krupp Krankenhaus, 45131 Essen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Greifzu, Dr.</last_name>
    <phone>+49-7461-95-0</phone>
    <email>franziska.greifzu@aesculap.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lange</last_name>
    <email>katharina.lange@aesculap.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Alfried Krupp Krankenhaus Rüttenscheid</name>
      <address>
        <city>Essen</city>
        <zip>45131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco Niedergethmann, Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>November 19, 2019</study_first_submitted>
  <study_first_submitted_qc>November 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 25, 2019</study_first_posted>
  <last_update_submitted>January 22, 2020</last_update_submitted>
  <last_update_submitted_qc>January 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>colorectal cancer</keyword>
  <keyword>laparoscopic surgery</keyword>
  <keyword>Seal &amp; Cut</keyword>
  <keyword>Total Mesorectal Excision (TME)</keyword>
  <keyword>Partial Mesorectal Excision (PME)</keyword>
  <keyword>Complete Mesocolic Excision (CME)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

